PSA

Capsaicin patches help reduce post-shingles pain

Researchers at the University of Wisconsin have reported that those who sufferfrom post-herpetic neuralgia or pain following an attack of shingles can now getrelief through a patch of Capsaicin, the active ingredient of chili peppers.Shingles is caused the varicella zoster virus, which also causes chicken pox.Shingles results in the occurrence of painful rashes on one side of the body and...

Body Weight Found To Influence PSA Levels

A new study shows obese men generally have lower prostate specific antigen levels than men of normal weight. // However researchers say this finding suggests the PSA test may not be as good at identifying early prostate cancer in such men. Researchers studied about 2,800 men with no evidence of prostate cancer. Results showed PSA levels declined as weight increased. The association held...

Sudden Rise in PSA Dangerous for men

Prostate cancer is the second-leading cause of cancer death in men and kills nearly 30,000 men each year. The lifetime risk of being diagnosed, one in six, is higher than the one in eight risk of breast cancer in women. // A new study shows the rate of rise in prostate-specific antigen levels, or PSA velocity, before prostate cancer diagnosis is a more powerful indicator of eventual death...

Annual PSA screening reduces risk of prostate cancer deaths

Findings presented at the American Society of Therapeutic Radiation Oncology (ASTRO) reveal that yearly screening for prostate specific antigen (PSA) // significantly reduces the mortality associated with prostate cancer. Prostate cancer is the second most prevalent type of cancer found in men after skin cancer. The prostate itself is a small gland in the male reproductive system, which...

Age Can Affect PSA Reading And Prostate Cancer Diagnosis

Prostate specific antigen is a tumor marker, elevated level of which is strongly suggestive of prostate cancer in men. PSA testing is routinely used by doctors to spot early signs of prostate cancer, // if any. A new study has now suggested that a different criterion may be needed for establishment of prostate cancer diagnosis in young men and those above 70 years of age. The researc...

PSA Can Predicts The Treatment Response In Advanced Prostate Cancer

A new study that has been conducted by researchers from the University of Michigan (U-M) medical school states that patients with lower PSA levels, //7 months after therapy lived longer. According to a new multicentre study that has been conducted by the Southwest Oncology Group and led by researchers at the U-M Comprehensive Cancer Centre, that has been published in the August 20th i...

PSA Doubling Predicts Prostate Cancer Recurrence

A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical// prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from p...

Hair-Growth Drug Artificially Lowers Psa Levels in Prostate Cancer Screening

The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test,// the standard screening test for prostate cancer, a multicenter study has found. The study, involving 308 men ranging in age from 40 to 60 years old, is available online in the British medical journal The Lancet and is scheduled to be...

PSA Not a Good Predictor of Lethal Prostate Cancer

The amount of prostate-specific antigen (PSA) in a man’s bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease// does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute. Although men with untreated localized prostate cancer have high long-term survival rates...

High Pretreatment PSA Velocity Predicts Worse Outcome

The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study. The study found that a pre-treatment rate of PSA increase, called PSA velocity, of more than 2 ng/ml/year was strongly associated with a high risk of death from prostate cancer. Elevated PSA velocity was a stronger poor p...